Next Article in Journal
The Toxicological Profile of Active Pharmaceutical Ingredients–Containing Nanoparticles: Classification, Mechanistic Pathways, and Health Implications
Previous Article in Journal
Comparison of PERCIST5, imPERCIST5, and PERCIMT Criteria for Early Assessment of Pembrolizumab Response with FDG-PET/CT in Metastatic Bladder Cancer Patients
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(5), 702; https://doi.org/10.3390/ph18050702
Action Date Notes Link
article xml file uploaded 9 May 2025 13:53 CEST Original file -
article xml uploaded. 9 May 2025 13:53 CEST Update https://www.mdpi.com/1424-8247/18/5/702/xml
article pdf uploaded. 9 May 2025 13:53 CEST Version of Record https://www.mdpi.com/1424-8247/18/5/702/pdf
article html file updated 9 May 2025 13:54 CEST Original file https://www.mdpi.com/1424-8247/18/5/702/html
Back to TopTop